NIBIB Exploratory/Developmental Research Grant Program (R21) (Clinical Trial Optional)

Funder: National Institutes of Health

Due Date: 1/7/2021

Budget: Negotiable

Opportunity: PAR-18-433

https://grants.nih.gov/grants/guide/pa-files/PAR-18-433.html

This FOA will support exploratory/developmental research projects of interest to the NIBIB (https://www.nibib.nih.gov/research-funding). These studies are expected to lead to breakthroughs in development of innovative techniques, agents, methodologies, models, or their applications. These studies may involve considerable risk that should be balanced by the potential high impact on human-health and related research. Applicants are expected to propose novel biomedical research approaches for which there is no preliminary data to demonstrate the feasibility of the proposed project. A project may be exploratory, developmental, proof of concept, or high risk-high impact, and may be technology design-directed, discovery-driven, or hypothesis-driven.

Leave a Reply